Neonatal transient pseudohypoparathyroidism: could it be included among inactivating parathyroid hormone (PTH)/PTH-related protein signalling disorders?
10.6065/apem.2019.24.2.129
- Author:
Domenico Umberto DE ROSE
1
;
Alessandro PERRI
;
Francesca GALLINI
;
Francesca PRIOLO
;
Eloisa TIBERI
;
Giovanni VENTO
;
Enrico ZECCA
Author Information
1. Division of Neonatology, Department of Pediatrics, Fondazione Policlinico Universitario “A. Gemelli” IRCSS – Catholic University of the Sacred Heart, Rome, Italy. derosedomenicoumberto@gmail.com
- Publication Type:Case Report
- Keywords:
Pseudohypoparathyroidism;
Pseudohypoparathyroidism;
Hypocalcemic seizures;
Newborn;
Inactivating PTH/PTH-related protein signaling disorder;
Personalized medicine
- MeSH:
Calcium;
Classification;
Diagnosis;
Follow-Up Studies;
Humans;
Hyperphosphatemia;
Infant;
Infant, Newborn;
Parathyroid Hormone;
Precision Medicine;
Pseudohypoparathyroidism;
Seizures;
Vitamin D
- From:Annals of Pediatric Endocrinology & Metabolism
2019;24(2):129-132
- CountryRepublic of Korea
- Language:English
-
Abstract:
We report a case of transient pseudohypoparathyroidism in a full-term newborn that presented at 20 hours of life with hypocalcemic seizures, hyperphosphatemia and raised parathormone levels. The diagnosis of pseudohypoparathyroidism was made according to biochemical investigations. The infant was treated with calcium supplementation and vitamin D analog therapy, and he remained stable and symptom-free with normal serum biochemistries during follow-up. We suggest that transient pseudohypoparathyroidism of the newborn (ntPHP) might be included among inactivating parathyroid hormone (PTH)/PTH-related protein signaling disorders as defined by the classification schema recently proposed by the European Pseudohypoparathyroidism Network. To the best of our knowledge, this is the first report in which the new classification has been applied to a case of ntPHP.
